Boston Scientific is excited to host a hybrid Investor Day on September 20th, 2023, between 8:30 a.m. and 1:00 p.m. EST.

“Our results in the first half of 2023 exceeded our expectations and demonstrated the strength of our category leadership strategy, commitment to clinical evidence generation and the winning spirit of our global team. We are looking forward to connecting with you at our 2023 Investor Day, where our leadership team will provide more insight into our current pipeline, near-term key catalysts and long-range financial goals.”

Mike Mahoney
Chairman and CEO, Boston Scientific